After five years of sparring, Allergan has agreed to pay $4 million to settle claims by several former female sales reps who accused the company of a wide variety of discriminatory practices. These included inequitable pay and promotions, harassment, and hostility toward pregnant employees.

The proposed settlement, which must still be approved by a federal court judge, is the latest in a string of agreements to resolve such accusations against several drug makers over the past decade. In each case, female employees described egregious and gratuitous conduct that allegedly permeated the companies.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy